HEALTH
Defibrillation Lead Exceeds Expectations in Clinical Trial
![Defibrillation Lead Exceeds Expectations in Clinical Trial](https://connecticutnewspress.com/wp-content/uploads/2024/06/10408-defibrillation-lead-exceeds-expectations-in-clinical-trial.jpg)
BOSTON — An investigative small-diameter defibrillation lead for implantable cardioverter-defibrillators has exceeded its safety and efficacy expectations in a pivotal clinical trial. The LEADR trial implanted OmniaSecure leads in 643 patients. It found that almost 98% of the experimental leads were successfully implanted, and 99.5% were placed precisely in the desired location in the right …